Recruiting studies: Difficult To Treat Rheumatoid Arthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis
Phase 1/Phase 2 · 12 location(s) · Novartis Pharmaceuticals · NCT07048197 Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis
Phase N/A · 1 location(s) · Zhejiang Provincial People's Hospital · NCT07491016 Controlling Hyperactive Immunity With Long-lived Lymphocytes
Phase 1/Phase 2 · 6 location(s) · Quell Therapeutics Limited · NCT07473154 Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in
Phase N/A · 1 location(s) · Dongyi He · NCT07484243

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.